[
    [
        {
            "time": "2023-10-05",
            "original_text": "Biotech Stock Rockets 34% After Decision To Reacquire Its Drugs Pays Off",
            "features": {
                "keywords": [
                    "Biotech",
                    "Rockets",
                    "Reacquire",
                    "Drugs"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Biotech Stock Rockets 34% After Decision To Reacquire Its Drugs Pays Off",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "AbbVie (ABBV) Gains As Market Dips: What You Should Know",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Gains",
                    "Market",
                    "Dips"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "AbbVie (ABBV) Gains As Market Dips: What You Should Know",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recenity": 8
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "This is Why AbbVie (ABBV) is a Great Dividend Stock",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Dividend",
                    "Stock"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "This is Why AbbVie (ABBV) is a Great Dividend Stock",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]